Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
Open | $6.540 |
Close | - |
Volume / Avg. | 296.749K / 289.329K |
Day Range | 6.410 - 6.680 |
52 Wk Range | 1.860 - 6.790 |
Market Cap | $388.330M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 0.45% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by B of A Securities on Monday, March 25, 2024. The analyst firm set a price target for 11.00 expecting LYRA to rise to within 12 months (a possible 69.23% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $6.5 last updated Today at March 28, 2024 at 1:31 PM EDT.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.